Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endocrine targets in experimental shock.

Irshad H Chaudry1, T S Anantha Samy, Martin G Schwacha

  • 1Center for Surgical Research, Department of Surgery, University of Alabama at Birmingham School of Medicine, 35294-0019, USA. irshad.chaudry@ccc.uab.edu

The Journal of Trauma
|May 28, 2003
PubMed
Summary

Hormone therapies show promise for treating immune and cardiovascular depression after trauma-hemorrhagic shock. Novel agents like flutamide and estradiol may safely restore responses in male and female trauma victims.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extracellular Cold-Inducible RNA-Binding Protein: Progress from Discovery to Present.

International journal of molecular sciences·2025
Same author

Facing stress and inflammation: From the cell to the planet.

World journal of experimental medicine·2024
Same author

Divergent effects of tumor necrosis factor (TNF) in sepsis: a meta-analysis of experimental studies.

Critical care (London, England)·2024
Same author

Systemic and cerebro-cardiac biomarkers following traumatic brain injury: an interim analysis of randomized controlled clinical trial of early administration of beta blockers.

Scientific reports·2024
Same author

Surgical Oncology Heroes and Legends: Edward M. Copeland III, MD, as Interviewed by Kirby I. Bland, MD, FACS, MAMSE.

Annals of surgical oncology·2024
Same author

Surgical Oncology Heroes and Legends: Kirby I. Bland MD, FACS, MAMSE as Interviewed by V. Suzanne Klimberg, MD, PhD, MSHCT, MAMSE.

Annals of surgical oncology·2024

Area of Science:

  • Trauma and hemorrhagic shock research
  • Endocrinology and immunology
  • Gender-based medicine

Background:

  • Current sepsis treatments post-trauma are ineffective.
  • Gender significantly influences immune and cardiovascular responses to trauma-hemorrhagic shock.
  • Men experience cardiovascular depression and immunosuppression, while women do not.

Purpose of the Study:

  • To investigate alternative treatments for trauma-hemorrhagic shock.
  • To explore the role of endocrine targets in modulating immune and cardiovascular responses.
  • To evaluate the safety and efficacy of specific hormones and agents.

Main Methods:

  • Review of existing literature on gender, hormones, and trauma-hemorrhagic shock.
  • Experimental studies on hormone, antagonist, and steroid use.

Related Experiment Videos

  • Assessment of gastrointestinal, hepatic, and renal functions.

    • Main Results:

    • Trauma-hemorrhagic shock elicits gender-specific immune and cardiovascular responses.
    • Hormones, antagonists, and steroids can restore depressed responses without adverse effects.
    • Flutamide, dehydroepiandrosterone, metoclopramide, and 17beta-estradiol are safe and effective.

    Conclusions:

    • Endocrine targets offer a novel therapeutic approach for trauma-hemorrhagic shock.
    • Specific hormones and agents can safely treat immune and cardiovascular depression.
    • These findings may lead to improved outcomes for trauma victims.